Navigation Links
Ferring Pharmaceuticals Inc. Recognized for Best-in-Class Work-Life Portfolio
Date:1/30/2013

PARSIPPANY, N.J., Jan. 30, 2013 /PRNewswire/ -- Ferring Pharmaceuticals was one of 54 honorees receiving WorldatWork's Alliance for Work-Life Progress (AWLP) 2013 Work-Life Seal of Distinction.  The award recognizes both public and private sector organizations from a variety of industries that have shown leadership in workplace strategies and practices to achieve success in work-life effectiveness.

"Ferring values the commitment that our colleagues make to the company," said Aaron Graff , President and COO of Ferring Pharmaceuticals Inc.  "We also know how important it is to establish a Ferring culture which allows us to balance work life with home life, and we are proud to be designated as a national leader in this regard."

Applicants for the AWLP seal were evaluated based on their work-life portfolio, including areas spanning dependent care, health and wellness, workplace flexibility, financial support, paid and unpaid time off, community involvement and efforts to transform organizational culture. 

Some of the specific programs of note offered at Ferring include:

  • Wellness initiatives, such as fitness related subsidies, on-site immunization clinics and a branded wellness program
  • Opportunities for workplace flexibility (e.g., flextime, phased return-to-work after FMLA-eligible leave)
  • Financial support through reimbursement of adoption and tuition expenses and college scholarships for employees' children
  • Company-sponsored retirement programs, including a traditional 401(k) match program and a supplemental employer-funded retirement plan
  • Community volunteer opportunities

For more details regarding the Work-Life Seal of Distinction, please visit http://www.awlp.org/awlp/seal/index.html.  To learn more about the Ferring Pharmaceuticals, visit www.ferringUSA.com.

About Ferring Pharmaceuticals
Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of reproductive health, urologygastroenterologyendocrinology and osteoarthritis. For more information, visit www.ferringUSA.com.


'/>"/>
SOURCE Ferring Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ferring Pharmaceuticals Inc. Named 10th Fastest Growing New Jersey Company
2. ESTEVE Fosters R & D by Transferring its Center for Drug Discovery to the Science Park of Barcelona (PCB)
3. Morgan & Morgan Announces Investigation of MAP Pharmaceuticals (NASDAQ: MAPP)
4. Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock
5. Avanir Pharmaceuticals Announces Date Of Fiscal 2013 First Quarter Financial Results And Conference Call
6. Keryx Biopharmaceuticals Announces $55 Million Proposed Public Offering of Common Stock
7. Cumberland Pharmaceuticals And PT. SOHO Industri Pharmasi enter Into Exclusive Licensing Agreement For Caldolor In Indonesia
8. Actinium Pharmaceuticals to Present at EMIT Targeted Radiotherapy Conference
9. Questcor Pharmaceuticals Appoints Michael Aldridge to the Position of Senior Vice President, Corporate Strategic Development
10. Auxilium Pharmaceuticals, Inc. Announces Pricing of $325.0 Million of 1.50% Convertible Senior Notes Due 2018
11. Ryan & Maniskas, LLP Announces Investigation of MAP Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the European ... system called the HORIZON at MIBio 2017 in Cambridge, ... and visible particulate matter in biopharmaceutical samples with unprecedented speed and ... the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/28/2017)... -- Cohen Veterans Bioscience and Early Signal Foundation announce ... home sensors for real-time monitoring of patients with trauma-related ... organization focused on disruptive health solutions for rare disorders ... to record and integrate behavioral, cognitive, physiological and contextual ... ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
(Date:10/12/2017)... , ... October 12, 2017 , ... The American College ... to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in ... , In honor of Morris F. Collen, a pioneer in the field of medical ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
Breaking Medicine News(10 mins):